Sponsored Content | Webinar | Radiation Therapy| October 13, 2017

WEBINAR: Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation

Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.

The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" was presented by Parag Parikh, BSE, M.D., associate professor of radiation oncology and biomedical engineering at Washington University in St. Louis, and Percy Lee, M.D., associate professor and vice chair of education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. They will share their ongoing experience in using MR-guided radiation therapy to treat pancreatic cancer.

The webinar took place Tuesday, Oct. 24, 2017.

View the archived webinar.

This presentation includes highlights of significant outcomes and treatment protocols currently used with their patients. The webinar will compliment the presenters' poster published at ASTRO17, “Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients," which provided a retrospective review of 42 locally-advanced pancreatic cancer patients treated at four institutions:

- Washington University and Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis

- University of California, Los Angeles Health System and Jonsson Comprehensive Cancer Center

- University of Wisconsin Carbone Cancer Center in Madison

- VU University Medical Center in Amsterdam, Netherlands

The study found that stereotactic dosing regimens guided by MR imaging using the MRIdian system and daily online adaptation had led to significantly prolonged patient survival and resulted in favorably low toxicity.

 

Presenters:

Percy Lee, M.D.Percy Lee, M.D.
Associate Professor Vice Chair, Education Director, Stereotactic Body Radiation Therapy Program
David Geffen School of Medicine at UCLA , UCLA Jonsson Comprehensive Cancer Center

Dr. Lee is an associate professor and vice chair of education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. Lee is the clinical director of the stereotactic body radiation therapy (SBRT) program and the chief of service for the thoracic and GI radiation cncology programs in the department. He also serves as the residency training program drector as well as the director for the medical student clerkship. Lee attended the Johns Hopkins University and graduated with the highest honors majoring in biomedical engineering with a concentration in chemical engineering. He attended Harvard Medical School and the Harvard-MIT Health Science and Technology Program where he received his M.D., and graduated magna cum laude. At Harvard, he was also a Howard Hughes Medical Institute fellow. He interned at the Massachusetts General Hospital and received specialty training in radiation oncology from Stanford University School of Medicine.

 

Parag Parikh, BSE, M.DParag Parikh, BSE, M.D
BSE Associate Professor of Radiation Oncology
Washington University School of Medicine in St. Louis 

Parag Parikh, BSE, M.D. is an associate professor of radiation oncology and biomedical engineering at Washington University in St. Louis. He serves as the chief of the gastrointestinal radiation oncology service at Washington University School of Medicine – Barnes Jewish Hospital - Siteman Cancer Center. He sees 400 new patients with pancreatic, liver, rectal and anal cancers per year. He has been routinely using MR-guided radiation therapy for three years, and will be coordinating a multicenter trial with UCLA and other institutions that looks at high dose radiation delivered with MR-guided radiation therapy to treat pancreatic cancer.

 

About ViewRay

ViewRay Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay Inc.

 

View the archived webinar.

Related Content

The top two videos on ITN for the year both involved medical imaging of COVID using point of care ultrasound (POCUS) and mass movement to teleradiology to enable remote working for radiologists and virtual collaboration with referring physicians. The image on the left is Butterfly's POCUS system that turns a smart phone into an ultrasound machine and the image is of COVID B-lines in the lung. The image on the right is a CT scan of COVID pneumonia. #COVID19

The top two videos on ITN for the year both involved medical imaging of COVID using point of care ultrasound (POCUS) and mass movement to teleradiology to enable remote working for radiologists and virtual collaboration with referring physicians. The image on the left is Butterfly's POCUS system that turns a smart phone into an ultrasound machine and the image is of COVID B-lines in the lung. The image on the right is a CT scan of COVID pneumonia. 

Feature | December 23, 2020 | Dave Fornell, Editor
Here are the top 25 best performing videos on the Imaging Technology News website (ITN) from the past year, based on
A multidisciplinary team of researchers have demonstrated production, purification, and potential for the 134Ce/134La in vivo generator as a PET imaging surrogate for 225Ac and 227Th radiotherapeutic agents.

A multidisciplinary team of researchers have demonstrated production, purification, and potential for the 134Ce/134La in vivo generator as a PET imaging surrogate for 225Ac and 227Th radiotherapeutic agents.

News | Nuclear Imaging | December 22, 2020
December 22, 2020 — Researchers in the DO...
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.

Image courtesy of Zeiss

News | Radiation Therapy | December 21, 2020
December 21, 2020 — According to recent studies, an increase in the...
The key trends oClinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | December 17, 2020 | By Melinda Taschetta-Millane and Dave Fornell
Intelerad Acquires Digisonics CVIS and OB?GYN reporting systems to Expand its Enterprise Imaging Workflow
News | Enterprise Imaging | December 16, 2020
December 16, 2020 - Intelerad Medical Systems, a provider of...
A recent Johns Hopkins Medicine study uses a computer model to predict the number of COVID-19 infections among health care workers in four different scenarios based on data from early in the pandemic. Graphic created by M.E. Newman, Johns Hopkins Medicine, from data in Razzak et al, PLOS ONE 15(12): e0242589

A recent Johns Hopkins Medicine study uses a computer model to predict the number of COVID-19 infections among health care workers in four different scenarios based on data from early in the pandemic. Graphic created by M.E. Newman, Johns Hopkins Medicine, from data in Razzak et al, PLOS ONE 15(12): e0242589

News | Coronavirus (COVID-19) | December 16, 2020
December 16, 2020 — During the COVID-19 pandemic
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium

Getty Images

News | Radiation Therapy | December 15, 2020
December 15, 2020 — Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy